MedTrace Logo

Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement

NCT00306917 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2022-07-19

Study results available
· View outcomes & findings →

Summary

Prospective, randomized study of Summit Porocoat versus Summit DuoFix HA in total hip arthroplasty

Conditions

Interventions

DEVICE

non-coated femoral hip stem

total hip replacement

DEVICE

coated femoral hip stem

total hip replacement

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • David A Fisher, MD · Orthopaedics Indianapolis

  • J W Mesko, MD · Michigan Orthopaedics Center

  • Paul Perona, MD · St Margaret's Hospital Family Orthopaedics

  • Stephan B Lowe, MD · Orthopaedic Specialists of the Carolinas

  • Donald L Pomeroy, MD · Pomeroy & Reddy

  • Nithin Reddy, MD · Pomeroy & Reddy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-01
Primary Completion
2009-01-29
Completion
2009-01-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00306917 on ClinicalTrials.gov